NPO Petrovax Pharm LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NPO Petrovax Pharm LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH400513D
  • |
  • Pages: 24
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

NPO Petrovax Pharm LLC (Petrovax) focuses on the research, development and manufacturing of medicines and vaccines. The company's expertise spans in producing APIs and liquid, semi-solid, and solid dosage forms in ampoules, plastic containers, vials and disposable syringes. It also provides cosmetic and veterinary products. Petrovax offers products in the therapeutic areas of infection diseases, immunology, urology, gynecology, and reproductive health. The company works in partnership with pharmaceutical companies and research and development institutions to develop new products. It commercializes its products in Ukraine, Belarus, Kazakhstan, Kyrgyzstan, Azerbaijan, Uzbekistan, Georgia, Moldova and Slovakia among others. Petrovax is headquartered in Moscow, Russia.

NPO Petrovax Pharm LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Petrovax Pharm Enters into Cooperation Agreement with Scientific Research Institute of Vaccines 10

Acquisition 11

Interros Acquires Controlling Stake in NPO Petrovax Pharm, Vaccine Maker 11

Russian Authorities Reject Abbott's Bid To Acquire 62.5% Stake In Petrovax Pharm, Drug Manufacturer 12

NPO Petrovax Pharm LLC-Key Competitors 14

NPO Petrovax Pharm LLC-Key Employees 15

NPO Petrovax Pharm LLC-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Recent Developments 17

Legal and Regulatory 17

Oct 18, 2017: Petrovax Pharm successfully certified for ISO 9001:2015 conformity 17

Mar 09, 2017: NPO Petrovax Pharm recertified for Russian GMP conformance of pharmaceutical manufacture and Quality Management System 18

Product News 19

Oct 10, 2017: Innovative thrombolytics for acute myocardial infarction readily accessible for Russian patients 19

May 16, 2017: Commercial batches of localized innovative thrombolytics to be launched to Russian market in June 20

Mar 13, 2017: NPO Petrovax Pharm launched PHARDO system for trial period 22

Other Significant Developments 23

May 06, 2017: Navicon updated CRM system at Petrovax Pharm 23

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24

List of Figures

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

List of Tables

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Key Facts 2

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

NPO Petrovax Pharm LLC, Deals By Therapy Area, 2012 to YTD 2018 8

NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Petrovax Pharm Enters into Cooperation Agreement with Scientific Research Institute of Vaccines 10

Interros Acquires Controlling Stake in NPO Petrovax Pharm, Vaccine Maker 11

Russian Authorities Reject Abbott's Bid To Acquire 62.5% Stake In Petrovax Pharm, Drug Manufacturer 12

NPO Petrovax Pharm LLC, Key Competitors 14

NPO Petrovax Pharm LLC, Key Employees 15

NPO Petrovax Pharm LLC, Other Locations 16

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

NPO Petrovax Pharm LLC, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 18225
Site License
USD 500 INR 36450
Corporate User License
USD 750 INR 54675

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com